Boosting Antitumour Immunity through Targeted Delivery of Interferon-α.
Sign Up to like & getrecommendations! Published in 2019 at "Trends in molecular medicine"
DOI: 10.1016/j.molmed.2019.09.001
Abstract: Immune checkpoint inhibitors (ICIs) have revolutionised cancer immunotherapy but their success is wholly dependent on amplifying an existing immune response directed against the tumour. A recent study by Tsuchiya et al. suggests how the properties of… read more here.
Keywords: boosting antitumour; delivery interferon; targeted delivery; antitumour immunity ... See more keywords